BE854413A - Composition pharmaceutiques pour l'induction d'une reponse oestrogene, et procede utilisant ces compositions - Google Patents

Composition pharmaceutiques pour l'induction d'une reponse oestrogene, et procede utilisant ces compositions

Info

Publication number
BE854413A
BE854413A BE177398A BE177398A BE854413A BE 854413 A BE854413 A BE 854413A BE 177398 A BE177398 A BE 177398A BE 177398 A BE177398 A BE 177398A BE 854413 A BE854413 A BE 854413A
Authority
BE
Belgium
Prior art keywords
eestrogen
induction
compositions
response
pharmaceutical composition
Prior art date
Application number
BE177398A
Other languages
English (en)
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of BE854413A publication Critical patent/BE854413A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE177398A 1976-05-10 1977-05-09 Composition pharmaceutiques pour l'induction d'une reponse oestrogene, et procede utilisant ces compositions BE854413A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/684,944 US4078060A (en) 1976-05-10 1976-05-10 Method of inducing an estrogenic response

Publications (1)

Publication Number Publication Date
BE854413A true BE854413A (fr) 1977-09-01

Family

ID=24750162

Family Applications (1)

Application Number Title Priority Date Filing Date
BE177398A BE854413A (fr) 1976-05-10 1977-05-09 Composition pharmaceutiques pour l'induction d'une reponse oestrogene, et procede utilisant ces compositions

Country Status (4)

Country Link
US (1) US4078060A (fr)
BE (1) BE854413A (fr)
PH (1) PH14505A (fr)
ZA (1) ZA772089B (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3273430B2 (ja) * 1989-12-28 2002-04-08 日東電工株式会社 エストロゲン含有ゲル製剤
CN1120314A (zh) * 1993-04-02 1996-04-10 加利福尼亚大学董事会 治疗骨质疏松症的方法和组合物
US5494899A (en) * 1993-04-07 1996-02-27 Oklahoma Medical Research Foundation Selective regulation of B lymphocyte precursors by hormones
SE9301171D0 (sv) * 1993-04-07 1993-04-07 Ab Astra Pharmaceutical composition containing lipophilic drugs
US5612317A (en) * 1994-08-04 1997-03-18 Holick; Michael F. Method for delivering estrogen
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) * 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US20030215412A1 (en) * 2000-07-21 2003-11-20 Essentia Biosystems, Inc. Induction of hair growth with vascular endothelial growth factor
US20040220100A1 (en) * 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
AU2003216389A1 (en) * 2002-02-21 2003-09-09 Essentia Biosystems, Inc. Induction of hair growth with vascular endothelial growth factor
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP2007527431A (ja) * 2004-03-03 2007-09-27 ルバンス セラピュティックス 局所的診断及び治療用の輸送のための組成物及び方法
BRPI0508410B8 (pt) * 2004-03-03 2021-05-25 Revance Therapeutics Inc composições e métodos para a aplicação tópica e liberação transdérmica de toxinas botulínicas
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (fr) 2005-02-03 2006-08-10 Alza Corporation Solutions de solvant/polymere utilisees comme vehicules de suspension
ZA200707352B (en) 2005-03-03 2009-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
MX2007010674A (es) * 2005-03-03 2007-11-08 Revance Therapeutics Inc Composiciones y metodos para la aplicacion topica y el suministro transdermico de un oligopeptido.
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
GEP20125432B (en) 2005-10-12 2012-03-26 Unimed Pharmaceuticals Llc Improved testosterone gel and use thereof
CN103126971A (zh) * 2005-11-17 2013-06-05 雷文斯治疗公司 减少非毒素蛋白质的肉毒杆菌毒素组合物和其局部施用及透皮递送方法
KR101106510B1 (ko) 2006-05-30 2012-01-20 인타르시아 세라퓨틱스 인코포레이티드 투피스, 내부채널 삼투압 전달 시스템 유동 조절기
EP2359808B1 (fr) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Système de libération osmotique avec ensemble de piston
US20100021502A1 (en) * 2006-12-28 2010-01-28 Waugh Jacob M Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabililzed with Polypeptide Fragments Derived from HIV-TAT
CN102988995A (zh) * 2006-12-29 2013-03-27 雷文斯治疗公司 用源自hiv-tat的多肽片段稳定的肉毒杆菌毒素的组合物及其局部施用和透皮递送的方法
BRPI0720729A2 (pt) * 2006-12-29 2014-04-08 Revance Therapeutics Inc Moléculas de transporte que utilizam polipeptídeos hiv-tat de sequência inversa.
WO2008133908A2 (fr) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Formulations en suspension de peptides insulinotropes et leurs utilisations
CA2726861C (fr) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Dispositifs, formulations et methodes d'administration de plusieurs agents benefiques
RU2547990C2 (ru) 2009-09-28 2015-04-10 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
RU2730996C2 (ru) 2015-06-03 2020-08-26 Интарсия Терапьютикс, Инк. Системы установки и извлечения имплантата
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
JP7286542B2 (ja) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド Ｇｌｐ－１受容体アゴニストの持続的投与及び薬物の同時投与を含む方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449381A (en) * 1962-06-12 1969-06-10 Syntex Corp 19-oxo- and 19-lower alkyl-19-oxoandrostane derivatives

Also Published As

Publication number Publication date
US4078060A (en) 1978-03-07
ZA772089B (en) 1978-06-28
PH14505A (en) 1981-08-21

Similar Documents

Publication Publication Date Title
BE854413A (fr) Composition pharmaceutiques pour l'induction d'une reponse oestrogene, et procede utilisant ces compositions
BE849632A (fr) Composition pharmaceutique pour l'administration orale
BE847742A (fr) Nouvelles imidazolidines, procede de preparation et compositions pharmaceutiques
FR2304945A1 (fr) Procede pour la reproduction tramee d'images en demi-teinte
PT64770B (fr) Procede pour la preparation d'une composition insecticide contenant ethers benzoilureide-difenilicos.
NL930110I2 (nl) Carbazolyl-(4)-oxypropanolamine-derivaten, werkwijze ter bereiding daarvan en geneesmiddelen, die deze verbindingen bevatten.
FR2328792A1 (fr) Compositions pour l'assouplissement des etoffes
FR2338271A1 (fr) Derives du phtalane, procede pour leur preparation, et compositions pharmaceutiques contenant de tels derives
RO68441A (fr) Procede pour la preparation des derives d'erythromycylamine
BE854368A (fr) Composition et procede pour inhiber la corrosion
FR2308127A1 (fr) Composition photosensible et procede pour la production d'images en relief
PT64771B (fr) Procede pour la preparation d'une composition insecticide contenant ethers benzoilureide-nitro-difenilicos.
FR2297895A1 (fr) Composition d'asphalte, destinee par
FR2312233A1 (fr) Nouvelle composition pour la teinture des cheveux et procede d'application
FR2325108A1 (fr) Procede de transmission d'information et systeme pour l'application de ce procede
BE847513A (fr) Composition pour l'acceleration de la prise du platre de construction,et produits realises en utilisant une telle composition
PT66174A (fr) Procede pour la preparation de derives de ditiole-1,2 et de compositions qu'en contiennent
FR2328281A1 (fr) Procede pour l'irradiation corpusculaire d'une preparation
FR2299026A1 (fr) Zhiourees et thiocarbamates, procede pour les preparer et compositions pharmaceutiques les contenant
FR2323801A1 (fr) Procede de teinture et compositions pour l'application du procede
PT66850B (fr) Procede pour la preparation d'une composition pharmaceutique
FR2300493A1 (fr) Herse souple, particulierement pour l'entretien des prairies
BE863359A (fr) Nouvelles glycoproteines isolees d'hafnia, procede de preparation et compositions pharmaceutiques
BE848374A (fr) Nouveau procede pour isoler des agents actifs d'extraits vegetaux,
BE858692A (fr) Composition pour le traitement de l'acne

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: RICHARDSON-MERRELL INC.

Effective date: 19920531